Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
In this dry form they are stable for months to years
The researchers hypothesized that weight loss with AOD9604 was driven by the beta-adrenergic pathway, more specifically the beta(3)-adrenergic receptors
Compared to NSAIDs: No gastrointestinal toxicity No cardiac risks No kidney damage risk No drug interactions Actively promotes healing rather than masking symptoms Compared to corticosteroids: No immunosuppression No bone density loss No endocrine disruption No adrenal suppression Promotes healing rather than suppressing inflammation Compared to other peptides: Similar or better safety profile Minimal side effects No hormonal disruption Well tolerated across populations Regulatory and Ethical Considerations Researchers should be aware of the regulatory status
(2014) Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health J Endocrinol Metab 4(1-2):114
US$ 20.89
US$ 27.48
US$ 25.44
US$ 29.93
US$ 20.91
US$ 21.15
US$ 25.08
US$ 21.50
